chr11-128969239-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001378024.1(ARHGAP32):c.5974G>A(p.Val1992Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001378024.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP32 | NM_001378024.1 | c.5974G>A | p.Val1992Ile | missense_variant | 23/23 | ENST00000682385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP32 | ENST00000682385.1 | c.5974G>A | p.Val1992Ile | missense_variant | 23/23 | NM_001378024.1 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251288Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135794
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461726Hom.: 0 Cov.: 30 AF XY: 0.0000385 AC XY: 28AN XY: 727138
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.5932G>A (p.V1978I) alteration is located in exon 22 (coding exon 22) of the ARHGAP32 gene. This alteration results from a G to A substitution at nucleotide position 5932, causing the valine (V) at amino acid position 1978 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at